Recent research has identified key enzymes involved in CD4+ T cell differentiation and the Kennedy pathway—ETNK1, PCYT2, and SELENOI—suggesting a potential correlation between SELENOI and tumor immunity.25, 26. The gene discussed is CD4; the disease is neoplasm.